- Senior Investigator, Cancer and Inflammation Program
Dr. Klinman received his MD/PhD from the University of Pennsylvania, and completed his fellowship training in Rheumatology at the National Institute of Arthritis, NIH. He headed the Section of Viral Immunology at the Center for Biologics Evaluation and Research of the FDA before joining the Laboratory of Experimental Immunology of the National Cancer Institute as chief of the Immunoregulation Group. He has authored over 300 peer reviewed articles, received of the FDA's 'Outstanding Scientist of the Year' Award, the 'Outstanding Achievement Award In Biology' from the Washington Academy of Science, and 'Meritorious', 'Outstanding' and 'Distinguished' Service Medals from the Public Health Service, among other honors.
- (2019). Critical Role of B Cells in Toll-Like Receptor 7-Mediated Protection against Listeria monocytogenes Infection. INFECTION AND IMMUNITY. 87(12),
- (2019). Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response. JOURNAL OF CLINICAL INVESTIGATION. 129(3), 1314-1328.
- (2019). PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus. JOURNAL OF AUTOIMMUNITY. 99, 24-32.
- (2018). Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer. Science Signaling. 11(511),
- (2018). Factors influencing the Differentiation of human Monocytic Myeloid-Derived suppressor cells into inflammatory Macrophages. Frontiers in Immunology. 9,